MIR519C: A Potential Drug Target and Biomarker (G574466)

Target Name: MIR519C

NCBI ID: G574466

MIR519C

MIR519C: A Potential Drug Target and Biomarker

Mir519C, also known as passenger 519C, is a protein that is expressed in various tissues of the human body, including the brain, lungs, and gastrointestinal tract. It is a member of the Mir gene family, which encodes for a family of transmembrane proteins that play a critical role in cell signaling.

Recent studies have identified MIR519C as a potential drug target and biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. MIR519C has also been shown to be involved in several cellular processes that are important for human health, including cell signaling, angiogenesis , and inflammation.

Drugs that target MIR519C have the potential to treat a wide range of diseases. For example, MIR519C has been shown to be involved in the development and progression of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease. By blocking the activity of MIR519C, researchers have been able to reduce the growth of neurodegenerate plaque in the brains of mice and improve cognitive function in animal models of these diseases.

MIR519C has also been shown to be involved in cancer, particularly in the regulation of cell proliferation. By inhibiting the activity of MIR519C, researchers have been able to inhibit the growth of cancer cells and reduce their ability to spread. This has the potential to be a useful treatment for a variety of cancers, including breast, lung, and ovarian cancer.

In addition to its potential as a drug target, MIR519C has also been shown to be a potential biomarker for several diseases. For example, MIR519C has been shown to be expressed in the brains of individuals with Alzheimer's disease, and levels of MIR519C have been shown to be decreased in the brains of individuals with neurodegenerative diseases. This suggests that MIR519C may be a useful biomarker for these diseases and could be used to diagnose and monitor the progression of these conditions.

MIR519C is also a potential target for drug development due to its unique structure and expression pattern. Unlike many other proteins, MIR519C is expressed in all tissues of the body and has a highly conserved sequence across its gene. This makes it a promising target for small molecules, antibodies, and other therapeutic agents.

In conclusion, MIR519C is a protein that has the potential to be a drug target and biomarker for a wide range of diseases. Its unique structure and expression pattern make it an attractive target for small molecules and other therapeutic agents. Further research is needed to fully understand the role of MIR519C in human health and to develop effective treatments for the diseases that are associated with its expression.

Protein Name: MicroRNA 519c

The "MIR519C Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR519C comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets